Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;52(1):167-170.
doi: 10.1111/cea.14043. Epub 2021 Nov 15.

Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain

Pablo Rodriguez Del Rio  1   2 , Davide Caimmi  3   4 , Pilar Rico  5 , Carmen Vidal  6 , Moreno Carmen  7 , Ileana M Pintoiu  8 , Jose M Beitia Mazuecos  9 , David Gonzalez de Olano  10 , Pedro Cuesta Alvaro  11 , Pascal Demoly  3   4 , Moises A Calderon  12
Affiliations

Real-life report of allergen immunotherapy management during the COVID-19 outbreak in France and Spain

Pablo Rodriguez Del Rio et al. Clin Exp Allergy. 2022 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
AIT Management Strategies during COVID‐19. Legend: For new AIT comparisons, the 9 doctors not attending allergy clinic during the confinement were not included. For maintenance dosing strategies, more than one strategy could be selected. AIT, allergen immunotherapy; SCIT, subcutaneous immunotherapy; SLIT, sublingual immunotherapy
See this image and copyright information in PMC

Comment in

References

    1. Lescure F‐X, Bouadma L, Nguyen D, et al. Clinical and virological data of the first cases of COVID‐19 in Europe: a case series. Lancet Infect Dis. 2020;20(6):697‐706. - PMC - PubMed
    1. Shaker MS, Oppenheimer J, Grayson M, et al. COVID‐19: pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract. 2020;8(5):1477‐1488.e5. - PMC - PubMed
    1. Pfaar O, Klimek L, Jutel M, et al. COVID‐19 pandemic: practical considerations on the organization of an allergy clinic‐An EAACI/ARIA position paper. Allergy. 2021;76(3):648‐676. - PMC - PubMed
    1. Klimek L, Jutel M, Akdis C, et al. Handling of allergen immunotherapy in the COVID‐19 pandemic: an ARIA‐EAACI statement. Allergy. 2020;75(7):1546‐1554. - PMC - PubMed
    1. Caimmi Davide E, Demoly P. Allergen immunotherapy using NPP: Perspectives for the treatment and prevention of respiratory allergies; the case of pollinosis. REVUE FRANÇAISE D’ALLERGOLOGIE. 2019;59(8):617‐623.

Substances

Grants and funding